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Porcine hemagglutinating encephalomyelitis virus (PHEV) is a highly neurovirulent
coronavirus that can cause nervous symptoms in piglets with muscle tremors, hind limb
paralysis, and nystagmus. Whether some factors affect virus replication and proliferation
had not been fully understood in the course of nerve damage caused by PHEV infection.
In recent years, some reports suggested that miRNA might play a key regulatory role in
viral infection. In this study, we found the miR-21a-5p is notably up-regulated in the
brains of mice and N2a cells infected with PHEV, and it down-regulated the expression
of CASK-interactive protein1 (Caskin1) by directly targeting the 3′-UTR of Caskin1
using a Dual-Luciferase reporter assay. The over-expression of miR-21a-5p or Caskin1
knockdown in the host significantly contributes to PHEV proliferation. Conversely, the
silencing of miR-21a-5p by miR-21a-5p inhibitors suppressed the virus proliferation.
Taken together, our results indicate that Caskin1 is the direct target gene of miR-21a-5p,
and it is advantageous to virus proliferation by down-regulating Caskin1. These findings
may help in the development of strategies for therapeutic applications.
Keywords: porcine hemagglutinating encephalomyelitis virus, coronavirus, miR-21a-5p, Caskin1, neurologic
damage
INTRODUCTION
Porcine hemagglutinating encephalomyelitis is an acute and highly contagious disease in pigs,
mainly affecting piglets within 3 weeks of age, causing vomiting and wasting disease, as well
as obvious neurological symptoms. The disease has not yet effective prevention and treatment
measures currently. (Chen et al., 2011; Gao et al., 2011; Li Z. et al., 2016). The mortality rate ranges
from 20 to 100% (Lan et al., 2012, 2013). This disease is caused by a member of the Coronaviridae
family, which be known as porcine hemagglutinating encephalomyelitis virus (PHEV) (Dong et al.,
2014); it is an enveloped virus containing a non-segmented, single-stranded, positive-sense RNA
genome of approximately 30 kb. Pigs are the natural host of PHEV, but have been adapted to
replicate in mouse and mouse neuroblastoma N2a cells (Chen et al., 2011). PHEV is a highly
neurovirulent virus that spreads to the central nervous system via peripheral nerves (Dong et al.,
2015), but the mechanism of induction of nerve injury is unclear. It is of great scientific interest
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to study the pathogenesis of PHEV from the point of view of virus
infection and host protein interaction for the development of new
antiviral drugs and treatment programs.
microRNAs (miRNAs) are non-coding ssRNAs that are 19–
25 nt in length and post-transcriptionally regulate the expression
of multiple genes by combining with the 3′-untranslated region
(UTR) of their target messenger RNAs and thus become
crucial regulators in complex gene regulatory networks (He
and Hannon, 2004; Varnholt, 2008; Chi et al., 2009; Mallick
et al., 2009). Accumulating evidence indicates that miRNAs
play a important role in the infection of coronavirus and the
neurovirulent virus (Hasan et al., 2014; Lai et al., 2014; Song
et al., 2015; Zhu et al., 2015; Piedade and Azevedo-Pereira, 2016).
For example, during SARS coronavirus infection process, miR-
17∗, mir-574-5p, and miR-214, were up-regulated, and miR-98
and miR-223 were down regulated. Among these miRNAs, miR-
17∗, mir-574-5p inhibited the replication of SARS coronavirus,
whereas miR-214 contribute to immune escape of the bronchial
alveolar stem cells (BASC) (Mallick et al., 2009). miR-15b
modulates the inflammatory response during JEV infection by
negatively regulating RNF125 expression (Zhu et al., 2015). Our
previous research revealed that miR-21a-5p, which is highly
homologous with miR-21, was significantly increased in the
process of PHEV infection by a DNA microarray analysis (Data
are not published).
miR-21 is a multifaceted microRNA regulating the expression
of target genes involved in several cellular programs, such as cell
proliferation, migration, invasion, and metastasis (Krichevsky
and Gabriely, 2009; Zhang et al., 2013). The regulatory role of
miR-21 in process of viral infection was confirmed by a number
of studies and can be used as a target for the treatment of
viral diseases. For example, in the murine coxsackievirus B3
(CVB3)-induced myocarditis model, the expression of miR-21
was significantly reduced. The recovery of miR-21 expression
significantly relieved CVB3-induced myocarditis as shown by an
increased body weight, a reduced myocardial injury, a lowered
myocarditis score and an increased survival rate. Further study
showed that miR-21 protects against myocardial apoptosis by
specifically inhibiting the expression of its target programmed
cell death 4 (PDCD4). These data proved miR-21 might be
a novel target for the treatment of CVB3 infection and other
apoptosis-mediated cardiovascular diseases (He et al., 2013).
In this study, we sought to investigate the regulatory role
of miR-21 in PHEV proliferation and provide theoretical basis
for the development of a new therapeutic regimen for PHEV
infection.
MATERIALS AND METHODS
Cells, Virus, and Mice
Mouse neuroblastoma N2a cells (N2a) and a human cervical
carcinoma cell line (Hela) were obtained from Professor Xia
(Military Veterinary Institute, Academy of Military Medical
Sciences, Changchun, China). N2a cells and Hela cells were
maintained in Dulbecco’s Modified Eagle’s medium (DMEM)
(Gibco, USA) containing 10% fetal calf serum, 1% streptomycin,
1% penicillin, and were incubated at 37◦C in a wetted chamber
supplemented with 5% CO2. The PHEV strain HEV 67N
(GenBank: AY048917) was propagated in N2a cells. BALB/c mice
(3 weeks old) were obtained from the Laboratory Animal Centre,
Jilin University.
The Choice of Housekeeping Genes
Generally, U6 and GADPH are expressed at relatively constant
levels in normal and pathological conditions. These genes may
be used as housekeeping genes in brain damage (Chi et al., 2014;
Alarcon et al., 2015; Li G. et al., 2016; Shen et al., 2016). There are
no significant differences in the expression of U6 and GADPH
in the gene expression patterns in the cerebral cortex of mice
infected with PHEV detected using microarray in our previous
study (Lan et al., 2014), so we take them as internal reference
genes for the relative quantification of other genes in this study.
RT-PCR for miRNA and mRNA
Expression
miRNA-enriched total RNA was extracted from N2a cells,
Hela cells and brain tissues of mice infected with PHEV
using a miRNApure Mini Kit (cwbio, China). To analyze
Caskin1 (GenBank: NM_027937.2) mRNA expression, RNA
was extracted using Trizol, tissue: 50–100 mg tissue/ml,
cell: 10 cm3/ml. The concentration of RNA was detected by
spectrophotometer (Thermo Scientific). RNA was reverse
transcribed into cDNA by using the reverse transcription
kit (Takara, Japan). The quantification of miRNAs was
performed using the Bulge-LoopTM miRNA qRT-PCR Primer
Set (RiboBio, China). miR-21a-5p and Caskin1 expressions
were determined by RT-PCR using SYBR Green Master Mix
kit as described previously (Shen et al., 2016). The relative
expression was analyzed using the 2−11CT method. U6 and
GAPDH were used for normalization of miR-21a-5p and
Caskin1 expression, respectively (Shen et al., 2016). The cycle
conditions and the system for PCR were set according to the
manufacturer’s protocol. U6 and mmu-mir-21a-5p primers
were purchased from RiboBio. The primers for Caskin1 and
GAPDH were designed as follows: mouse Caskin1 sense
primer, 5′-GTGGGTCGGAGCCATTCA-3′; anti-sense primer,
5′-GCCGAGCTGGAGCGTTT-3′; mouse GAPDH sense
primer, 5′-CTCAACTACATGGTCTACATGTTC-3′; anti-sense
primer, 5′-ATTTGATGTTAGTGGGGTCTCGCTC-3′; HEV
sense primer, 5′-AGCGATGAGGCTATTCCGACTA-3′; and
anti-sense primer, 5′-TTGCCAGAATTGGCTCTACTACG-3′.
The PCR reaction system was 20 µL and reaction conditions:
pre-degeneration at 95◦C for 3 min, denaturation at 95◦C for
30 s, annealing at 60◦C for 30 s, extension at 72◦C for 30 s with
a total of 40 cycles. The amplification efficiency of PCR was
detected (Supplementary Data Sheet 1).
Cloning of the 3′-UTR/Caskin1
Dual-Luciferase Reporter Construct
The miR-21a-5p targets were predicted by TargetScan,
Microcosm and Miranda. Caskin1 was used as the research
object. The 3′-UTR of mouse Caskin1 gene, containing the
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putative miR-21a-5p binding site (Caskin1-WT-UTR), was
amplified from mouse genomic DNA by PCR. The 3′-UTR
of mouse Caskin1 gene, containing a mutant miR-21 binding
side (Caskin1-MUT-UTR), was created by overlap extension
of PCR. The Caskin1-WT-UTR and the Caskin1-MUT-UTR
were subcloned into pmirGLO Dual-Luciferase miRNA Target
Expression Vector (Promega, USA) at the Sac I and Xhol site
(Caskin1-WT and Caskin1-MUT, respectively). The primers for
the 3′-UTR of Caskin1 were as follows: Caskin1-WT-UTR sense
primer, 5′-GGCACAGCACAAGGGACA-3′; anti-sense primer,
5′-CAGTAAGAGCAAGGCACATCC-3′; Caskin1-MUT-UTR,
primer1, 5′-GGCACAGCACAAGGGACA-3′; primer2, 5′-TAC
TCCTTGATAGCGCATATTCAGGGGTGCAGTGGGGCG-3′
primer3; 5′-CGCCCCACTGCACCCCAGAATATGCGCTATCA
AGAGTA-3′ primer4; and 5′-CAGTAAGAGCAAGGCACA
TCC-3′.
Cell Transfection
Hela cells were plated in six-well plates at a density of 3 × 105
cells/well in DMEM containing 2% fetal bovine serum and
were grown overnight. X-tremeGENE HP DNA Transfection
Reagent (Roche, Sweden) was used to co-transfected Hela
cells with 50 nM miR-21a-5p mimic or 100 nM inhibitor or
their respective non-targeting negative control oligonucleotides
(RiboBio) and 2 µg of Caskin1-WT or Caskin1-MUT. The empty
plasmid pmirGLO group was used for the negative control,
and non-transfected Hela cells were used as the blank control.
After 48 h of transfection, luciferase activity was detected after
transfecting 48 h by using a dual luciferase reporter assay system
(Promega). Renilla luciferase activity was used for normalization.
N2a cells (3 × 105 cells per well) were seeded into six-
well culture plates, incubated overnight and transfected with
50 nM of the miR-21a-5p mimics or 100 nM of the miR-21a-
5p inhibitor or the Caskin1 siRNAs or the siRNA NC using
X-tremeGENE HP DNA Transfection Reagent (Roche). Their
respective non-targeting negative control oligonucleotides and
a scrambled siRNA (siNC) were used as the negative controls.
The cells were inoculated with virus 12 h after the transfection.
All the transfection experiments were repeated at least three
times.
Western Blotting Analysis
The cells in 6-well plates or brain tissues were washed once
with phosphate buffer saline (PBS), followed by lysis using a
Radio Immunoprecipitation Assay (RIPA) Lysis Buffer and a
Phenylmethanesulfonyl fluoride protease inhibitor (Beyotime)
on ice for 30 min. The concentration of protein was determined
by the BCA Protein Assay kit (Pierce). The protein samples
(50 mg/lane) were separated using a 10% polyacrylamide gels and
were transferred to 0.22 µm polyvinylidene fluoride membranes
using the Bio-Rad wet transfer system. After blocking overnight
at 4◦C with 5% non-fat dry milk in PBS, the membranes
were probed with antibodies against Caskin1 (Synaptic Systems,
Göttingen, 1:2000), β-actin (Proteintech, USA, 1:2000) and
PHEV (a laboratory-prepared polyclonal antibody to PHEV,
1:500) with an overnight incubation at 4◦C. Next, the membranes
were washed with PBS containing tween-20 (PBST) four
times and were incubated with horseradish peroxidase-linked
secondary anti-rabbit or anti-mouse IgG antibodies (Proteintech)
for 1 h at 37◦C. After washing with PBST, the signal was visualized
using an ECL detection kit (Proteintech). β-actin was used as a
loading control.
TCID50 Analysis
To determine the TCID50 of the virus culture collected at
different passages, the cell culture supernatants were serially
diluted from 10−1 to 10−8, and 100 µL of the diluted virus
was inoculated onto the N2a cells in each well of the 96-well
culture plates with eight wells for each dilution. The plates were
incubated for 3 days at 37◦C in 5% CO2 and were scored for a
cytopathic effect. The infectious titer was calculated by the Reed
and Muench method (Biacchesi et al., 2005).
PHEV Infection and miR-21a-5p
Antagomir Administration
The mice were randomly divided into four groups, six mice
in each group, as follows: group 1 was the control group;
group 2 was the PHEV-infected and PBS group (PBS); group
3 was the PHEV-infected and antagomir control group (NC);
and group 4 was the PHEV-infected and miR-21a-5p antagomir
treated group (antagomir). The miR-21a-5p antagomir used in
this study contains chemically modified single-stranded RNA
molecules which could prevent the complementary pairing of
miRNA and its target gene mRNA through the combination
of strong competitive with the mature miRNA in vivo were
purchased from RiboBio. The mice in the antagomir group were
injected intraperitoneally with 2 nmol antagomir per mouse. The
mice in the other groups were injected with the same volume
of control solution or not. The brain tissues were analyzed
24 h after an intracerebral injection to study the expression
of miR-21a-5p and Caskin1 by RT-PCR or Western blotting.
After 24 h of injection, mice were inoculated intranasally with
100 ml of PHEV solution (TCID50 = 10−4.5/0.1 ml). The
brain tissues were analyzed 5 days after the inoculation with
PHEV to analyze the expression of miR-21a-5p and Caskin1
and viral RNA by qRT-PCR or Western blotting. The weight
of the mice was measured every day. The permission to work
with laboratory animals was obtained from the Animal Welfare
Ethical Committee of the College of Veterinary Medicine, Jilin
University, China.
Indirect Immunofluorescence
After inoculation with PHEV, the mice were sacrificed, and the
brain tissues were cut into frozen-sections. The frozen-sections
or the cells grown in 6-well plates, after transfection, were
washed with PBS, fixed with 4% paraformaldehyde for 15 min
at room temperature, permeabilized with 0.1% Triton X-100 for
immunofluorescence for 15 min at room temperature and were
blocked with 5% non-fat milk powder for 1 h at 37◦C before
being washed with PBS and incubated overnight at 4◦C with a
PHEV polyclonal antibody. After washed with PBS three times,
the (FITC)-conjugated Affinipure Goat Anti-Mouse IgG (H+L)
secondary antibodies (Proteintech) were incubated with PBS at
Frontiers in Microbiology | www.frontiersin.org 3 March 2017 | Volume 8 | Article 304
fmicb-08-00304 February 27, 2017 Time: 16:47 # 4
Lv et al. miR-21a-5p Promotes PHEV Replication
37◦C 1 h. Hoechst was used to stain the nuclei. After washed with
PBS three times, the coverslips were mounted onto glass with
Antifade Solution (Solarbio) before visualization on a confocal
microscope.
Statistical Analysis
Values are presented as an arithmetic mean ± standard error.
All data were analyzed by SPSS 17.0 software (Chicago, USA).
Histogram was carried out with GraphPad Prism 5.0 software
(San Diego, CA, USA). Western blot pictures were analyzed by
Tanon Gis software (Shanghai, China). Fluorescence intensity
was analyzed by ImageJ software (National Institutes of Health,
USA). All results were considered statistically significant at the
p-values< 0.05 level.
RESULTS
miR-21a-5p Up-Regulation during the
PHEV Infection Process
To determine the differentiated expression of miR-21a-5p during
the PHEV infection process, we collected the N2a cells after
infection for 24, 48, and 60 h, and the mouse brain tissue
was infected for 3 and 5 days prior to the RT-PCR. The
results revealed that the relatively expression level of miR-21a-
5p was significantly higher after infection than in the control
(Figures 1A,B). Thus, we speculate that miR-21 might play a role
in the process of viral infection.
miR-21a-5p Promotes PHEV Replication
In vitro
To determine whether mir-21a-5p has effects on PHEV
replication, we tested the effect of upregulating or blocking miR-
21a-5p on PHEV replication in N2a cells. To figure out the
efficacy of the miR-21a-5p mimics and the inhibitor, the N2a
cells were transfected with the miR-21a-5p inhibitor or the miR-
21a-5p mimics for 24 h, and the expression level of miR-21a-5p
was analyzed. A significant increase or decrease was observed
in the miR-21a-5p level in the N2a cells transfected with the
miR-21a-5p mimics or the miR-21a-5p inhibitor, respectively,
compared to the cells transfected with the negative control
(Figure 1C). The N2a cells were transfected with the mimics or
the miR-21a-5p inhibitor (50 or 100 nM), followed by infection
with PHEV. The cells were collected 24 h post-infection to
determine the viral propagation. Among the RT-PCR, Western
blotting, IFA and TCID50 results, the overexpression of miR-
21a-5p significantly increased the progeny of PHEV production,
and conversely, the transfection of the miR-21a-5p inhibitor
demonstrated the opposite effects (Figures 1D–G). These
data suggest that miR-21a-5p induction contributes to PHEV
replication.
The Prediction of miR-21 Target Genes
To characterize the molecular components of miR-21a-5p
activity in facilitating PHEV replication, we next predicted
miR-21a-5p targets using bioinformatics prediction software.
TargetScan predicted 210, MicroCosm predicted 836 and
miRanda predicted 4990 target genes. Of these, 203 target genes
were predicted by all three systems. Then, the target genes
were functionally analyzed. We found that the target genes were
involved in a variety of physiological processes, such as cell
differentiation, proliferation, apoptosis, and synaptic function
(Supplementary Data Sheet 2). Part of results was demonstrated
in Table 1. Caskin1, a newly discovered post-synaptic density
protein in mammalian neurons, was used as the research
object.
miR-21a-5p Modulates Caskin1
Expression in PHEV-Infected N2a Cells
The time-dependent expression pattern of Caskin1 mRNA and
protein in the N2a cells and mouse brain tissue following
PHEV infection was studied. A significant down-regulation in
Caskin1 mRNA and protein expression at 24, 48, and 60-h
post-PHEV infection was observed (Figures 2A,B). The results
of the brain tissue detection in the mice were consistent with
the above findings (Figures 2C,D). The mRNA and protein
expression of Caskin1 also were determined after transfecting
with the miR-21a-5p mimics which could be over-expressed miR-
21a-5p. The expression of Caskin1 was significantly decreased
after transfection with miR-21a-5p mimics (Figures 2E,F).
Furthermore, the expression of Caskin1 in N2a cells following
transfection with the miR-21a-5p inhibitor was analyzed.
Inhibition the expression of miR-21a-5p caused the enhanced
expression of Caskin1 mRNA and protein (Figures 2E,F). It was
thus evident from the results that miR-21a-5p modulates Caskin1
expression.
miR-21a-5p Directly Regulates Caskin1
Expression by Targeting the 3′-UTR of
Caskin1
To test whether miR-21a-5p directly regulates the expression
of Caskin1 in the process of the PHEV infection, we
prepared a Dual-Luciferase miRNA Target Expression Vector
by binding the 3′-UTR of mouse Caskin1 which containing
an exact match to miR-21a-5p target sequence (Caskin1-WT-
UTR) (Figure 2G). We also created a Dual-luciferase miRNA
Target Expression Vector by binding the 3′-UTR of mouse
Caskin1 which containing a mismatched version of miR-21a-5p
target side (Caskin1-MUT-UTR) (Figure 2G) as control. Co-
transfection of the Dual-luciferase miRNA Target Expression
Vector containing the Caskin1-WT-UTR (Caskin1-WT) with
the miR-21a-5p mimics in the Hela cells resulted in an
approximate 90% loss of Dual-luciferase reporter expression
compared with the control (Figure 2H). However, the Dual-
luciferase expression was not affected by the co-transfection
with the miR-21a-5p mimics when the Caskin1-WT-UTR was
replaced with the Caskin1-MUT-UTR in the Dual-luciferase
reporter system (Figure 2H). Similarly, luciferase activity was
significantly increased when the Hela cells were transfected with
the miR-21a-5p inhibitor to inhibit the endogenous miR-21 levels
(Figure 2H). Taken together, these results indicate that miR-
21a-5p negatively regulates Caskin1 expression in the PHEV
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FIGURE 1 | miR-21a-5p was up-regulated during the porcine hemagglutinating encephalomyelitis virus (PHEV) replication process and promoted
PHEV replication. (A) N2a cells were infected with or without PHEV for different times as indicated. The expression of miR-21a-5p was measured by RT-PCR.
(B) miR-21a-5p expression in the BALB/c mice brain after infecting with PHEV as determined by RT-PCR. (C) The expression of miR-21a-5p in the N2a cells after
transfection with the indicated mimics or inhibitors of the indicated miR-21a-5p. (D) The levels of the virus genome RNA after transfection with the miR-21a-5p
mimics or inhibitor. (E) A Western blot was performed to examine the expression of the PHEV protein. (F) IFA was performed to examine the expression of PHEV.
(G) The PHEV titers in the N2a cell supernatants of the N2a cells after transfection with the miR-21a-5p mimics or inhibitor. All of the data are representative of at
least three independent experiments. ∗P < 0.05, ∗∗P < 0.01 vs. normal controls.
infection process by straightly binding the 3′-UTR of the Caskin1
gene.
miR-21a-5p Promotes PHEV Replication
by Targeting Caskin1 in the N2a Cells
Then we tested whether the expression of Caskin1 had an
effect on PHEV replication. First, the expression of endogenous
Caskin1 was reduced by transfecting Caskin1 siRNA in the
N2a cells. The results showed that more than 80% Caskin1
mRNA and protein levels was silenced in the N2a cells
(Figures 3A,B). Then, we examined the effect of reduced
Caskin1 expression on PHEV replication. PHEV replication was
significantly increased in the cells after reducing the expression
of Caskin1 compared to the cells transfecting with a negative-
control siRNA (Figures 3C–E). Cells in which Caskin1 was
silenced had a significant increasing trend in PHEV titers
compared to the control cells (Figure 3F). In conclusion,
these results indicate that Caskin1 is a conditioning factor
of PHEV replication and that PHEV makes use of miR-21a-
5p induction to decrease Caskin1 levels and conducive to its
replication.
Frontiers in Microbiology | www.frontiersin.org 5 March 2017 | Volume 8 | Article 304
fmicb-08-00304 February 27, 2017 Time: 16:47 # 6
Lv et al. miR-21a-5p Promotes PHEV Replication
TABLE 1 | The result of the miR-21a-5p target gene prediction.
mir base Matuacc mirna_name Gene symbol Gene description Score
mmu-miR-21a-5p MIMAT0000530 mmu-miR-21 Fnip1 Folliculin interacting protein 1 −0.25
mmu-miR-21a-5p MIMAT0000530 mmu-miR-21 Pcbp1 Poly(rC) binding protein 1 −0.25
mmu-miR-21a-5p MIMAT0000530 mmu-miR-21 Tmem170 Transmembrane protein 170 −0.24
mmu-miR-21a-5p MIMAT0000530 mmu-miR-21 Caskin1 CASK interacting protein 1 −0.23
mmu-miR-21a-5p MIMAT0000530 mmu-miR-21 Spg20 Spastic paraplegia 20, spartin (Troyer syndrome) homolog (human) −0.23
mmu-miR-21a-5p MIMAT0000530 mmu-miR-21 Chd7 Chromodomain helicase DNA binding protein 7 −0.23
mmu-miR-21a-5p MIMAT0000530 mmu-miR-21 Rpa2 Replication protein A2 −0.23
mmu-miR-21a-5p MIMAT0000530 mmu-miR-21 Klhdc5 Kelch domain containing 5 −0.23
mmu-miR-21a-5p MIMAT0000530 mmu-miR-21 Chic1 Cysteine-rich hydrophobic domain 1 −0.23
mmu-miR-21a-5p MIMAT0000530 mmu-miR-21 Jag1 Jagged 1 −0.22
FIGURE 2 | miR-21a-5p directly regulates Caskin1 expression by targeting the 3′-UTR of Caskin1. (A) Caskin1 mRNA expression in the N2a cells after
infecting with PHEV by RT-PCR. (B) The expression of Caskin1 in the N2a cells after infecting with PHEV by Western blot. (C) Caskin1 mRNA expression in the
BALB/c mice brain tissue after infecting with PHEV by RT-PCR. (D) The expression of Caskin1 in the BALB/c mice brain tissue after infecting with PHEV by Western
blot. (E,F) The expression of Caskin1 after transfection with the miR-21a-5p mimics or inhibitor by using RT-PCR (E) or Western blot (F). (G) The Dual-luciferase
reporter construct containing the wild type or mutant 3′-UTR of Caskin1. Caskin1-WT-UTR, sequence of the putative miR-21 binding site; Caskin1-MUT-UTR,
sequence of the mutant miR-21 binding site. (H) Dual-luciferase reporter activity in Hela cells 48 h post-transfection. All of the data are representative of at least three
independent experiments. ∗P < 0.05, ∗∗P < 0.01 vs. normal controls.
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FIGURE 3 | miR-21a-5p promotes PHEV replication by targeting Caskin1 in N2a cells. (A) Caskin1 mRNA levels in N2a cells 48 h post-transfection with
siRNAs. (B) Caskin1 protein levels in N2a cells 48 h post-transfection with Caskin1 siRNA. (C) The levels of the viral genome RNA after transfecting with Caskin1
siRNA. (D) Western blotting was performed to examine the expression of PHEV protein. (E) IFA was performed to examine the expression of PHEV. (F) Viral titers
from N2a cells transfected with Caskin1 siRNA. All of the data are representative of at least three independent experiments. ∗P < 0.05, ∗∗P < 0.01 vs. normal
controls.
miR-21a-5p Antagomir Treatment
Reduces Symptoms in PHEV-Infected
Mice
To determine whether miR-21a-5p inhibition was possible in
normal mice in vivo, the miR-21a-5p antagomir was injected
intracerebrally three times, at 3-day intervals (at days 0, 3, and
6). We detected miR-21a-5p expression in the brain tissue of the
different groups of mice. In the miR-21a-5p antagomir group, the
miR-21a-5p expression levels were significantly down-regulated
24 h after injection compared with the control (Figure 4A).
The result indicated that the miR-21a-5p antagomir efficiently
entered into the mouse brain tissue, resulting in the deletion of
miR-21a-5p in the mouse brain tissue.
On day 5 post-infection, the control group, the PBS group,
and the NC group mice exhibited typical symptoms of PHE
that included generalized muscle tremors and hyperesthesia.
However, the antagomir group did not have these typical
symptoms. At 7 dpi, the antagomir group appeared to have
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FIGURE 4 | miR-21a-5p antagomir treatment reduces symptoms in PHEV-infected mice. (A) The expression of miR-21a-5p in brain tissue 24 h after
injection. (B) Weight loss rate in the mice after treatment during PHEV infection. (C) The expression of miR-21a-5p in brain tissue 5 days after PHEV inoculation.
(D) The expression of Caskin1 mRNA in brain tissue 5 days after PHEV inoculation. (E) The expression of Caskin1 protein in brain tissue 5 days after PHEV
inoculation. (F) The relative expression of the viral RNA in brain tissue after treatment. (G) The expression of PHEV protein in brain tissue after treatment. (H) IFA was
performed to examine the expression of PHEV in brain tissue after treatment. All of the data are representative of at least three independent experiments. ∗P < 0.05,
∗∗P < 0.01 vs. normal controls.
the typical symptoms. Unfortunately, all of the mice in those
groups eventually died. In contrast, the antagomir group of mice
survived more than 2 days. In addition, compared with other
groups, the antagomir group of mice did not have an obvious
weight loss (Figure 4B). At 5 dpi, the mice were sacrificed, and
the brain samples were collected and processed for subsequent
experiments. The results were similar to those in vitro, it has a
negative relationship between the expression patterns of miR-
21a-5p and its target Caskin1 in the brain tissues from the
PHEV-infected mice, and the higher expression of miR-21a-5p
was associated with a low-level of Caskin1 (Figures 4C–E). In
the PHEV-infected mice, the treatment with the miR-21a-5p
antagomir caused a significant reduction in the miR-21a-5p
expression and rescued the alterations in the Caskin1 levels
(Figures 4C–E).
We used RT-PCR, IFA, and Western blotting to determine the
effects of the miR-21a-5p antagomir on the viral proliferation
after injection. The expression of viral RNA and protein
was down-regulated after injecting the miR-21a-5p antagomir
(Figures 4F,G). The results of the IFA indicated that the miR-
21a-5p antagomir had a certain effect on the proliferation of the
virus (Figure 4H). These findings affirm that the miR-21a-5p
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antagomir inhibits viral proliferation by up-regulating Caskin1
and has a therapeutic effect on animals.
DISCUSSION
Many studies show that miRNA and viral infection are closely
related processes, such as Epstein Barr virus, herpes virus
and some reverse transcription viruses because virus-encoded
miRNAs can regulate host cell endogenous miRNA expression
(Pfeffer et al., 2004). The host cell’s endogenous miRNA inhibits
the replication of the virus, and there could also be a virus that
facilitates viral replication or regulates cellular immune function
and so on (Sarkies et al., 2013). For example, the host cell miR-145
negatively regulates replication of the oncolytic herpes simplex
virus-1 by targeting AP27i145 (Li et al., 2013), and in influenza
virus infection, multiple proteases play a key role in the host cell
miRNA regulation of these proteases, which permits convenient
influenza virus replication (O’Connor et al., 2014). In addition,
miR-29b in the JEV-infected mouse microglial cell line was up-
regulated during JEV-induced microglial activation, and miR-29b
plays a role of the pro-inflammatory response. The mechanisms
of its action is mediated by inhibiting the anti-inflammatory
protein, TNFAIP3, resulting in the continuous activation of
NF-κB and followed by pro-inflammatory cytokine secretion
(Li et al., 2013).
Multiple miRNAs modulate the virus infection process, but
the roles of the miRNAs in the PHEV infection process are
not fully understood. Neurotropic viruses such as JEV, human
immunodeficiency virus 1, herpes simplex virus 1, and vesicular
stomatitis virus could cause host cell miRNA expression changes
during infection. The expression of miRNAs, which normally
regulates viral replication, was upregulated by 1.5–4-fold (Ashraf
et al., 2016). The previous research from our lab demonstrated
that the change in the miR-21a-5p expression was obvious in the
PHEV infection process, suggesting that miR-21a-5p might play
a very important role in the process of virus infection. PHEV
mainly causes obvious nerve injury, whereas miR-21 also plays
an important role in nerve injury. For example, in traumatic
brain injury, the expression of miR-21 was up-regulated 1.5-
fold in the brain cortex and hippocampus and might affect the
pathophysiology of traumatic brain injury (Redell et al., 2011).
In this study, we found that miR-21a-5p expression in N2a
cells was up-regulated after PHEV infection and increased up
to 2.5-fold at 60 h. The expression of miR-21a-5p was also
up-regulated in PHEV-infected mice and increased to 3.35-fold
at 5 days. This indicates that the expression level of miR-
21a-5p is significantly increased during PHEV-infected host,
suggesting that miR-21a-5p may play a role in PHEV-induced
neurotoxicity. In addition, the up-regulation of miR-21a-5p
expression promotes viral proliferation, and the knock-down
of the expression of miR-21a-5p reduces viral proliferation,
suggesting that miR-21a-5p affects PHEV proliferation. Unlike
other cells, nerve cells are very sensitive to injury, especially to
some neurotropic virus infections, such as PHEV. Small changes
in the amount of the viruses in the host neurons may cause
significant changes in the course of disease. In spite of siRNA
inhibition of Caskin1 showed a very modest inhibition of PHEV
replication (twofold) in neuronal cell cultures and even less of
an effect in mice, its impact on viral nerve injury may be very
large. Therefore, we speculated that miR-21a-5p might play an
important role in PHEV pathogenesis. Whether there are other
targets of miR-21a-5p affect viral replication is unclear during
PHEV infection.
miRNAs post-transcriptionally regulate the expression of
multiple genes by binding to the 3′-UTR of their target
messenger RNAs to play biological functions (Chi et al., 2009).
To determine the mechanism of miR-21a-5p affecting virus
proliferation, we predicted its target genes. There were many
target genes of miR-21, such as PTEN, PDCD4, RECK, TPM1,
TIMP-3, Maspin, and Sprouty (Spry-2, Spry-1) (Buscaglia and
Li, 2011). These target genes were involved in the process of
cell proliferation and apoptosis and so on. In this study, we
choose Caskin1 as the target gene to be detected. Caskin1
is a brain-specific multi-domain scaffold protein that binds
Lar and Dock through its different structural domains. In
addition, Caskin1 plays a key role in motor axon targeting
through interaction with the Lar-dependent signaling pathway
(Weng et al., 2011). In the CNS, Caskin1 and dock have
overlapping roles in axon outgrowth. Overall, these studies
indicate Caskin1 is required for neuronal axon growth and
guidance in the CNS. Together, these studies identify Caskin1
as a neuronal adaptor protein required for axon growth and
guidance (Weng et al., 2011). Time dynamics research to the
expression of miR-21a-5p and its target gene Caskin1 showed that
an inverse relationship with respect to each other’s expression
until the 24 h time point. The up-regulation of miR21a-
5p after PHEV infection showed a sustained changes at 24,
48, and 60 h; however, Caskin1 mRNA and protein levels
decreased 60 h post-infection compared to the 24 and 48 h time
points. It is possible that miR-21a-5p reduces the expression
of its target mRNA and protein (Caskin1). These results were
consistent with the above in vivo experiment. However, further
studies are required to resolve this issue of the differential
kinetics of miR-21a-5p and its target. In this study, we used
a luciferase reporter assay to evaluate the interaction of miR-
21a-5p with the 3′-UTR of Caskin1. It was evident from the
luciferase reporter assay that miR-21a-5p binds to this region
of Caskin1 and suppresses its expression. The knock-down of
the expression of Caskin1 in the N2a cells promotes virus
proliferation. Taken together, our findings demonstrate that
miR-21a-5p positively regulates PHEV replication by targeting
Caskin1.
To study the role of miRNA in vivo and its influence on
the viral diseases, the miRNA antagomir was used to reduce
the miRNA concentration. For example, after the miR-19b-3p
antagomir treatment, 40% of the JEV-infected mice became
asymptomatic, and the expression of miR-19b-3p showed a
reciprocal pattern with its target gene RNF11 in the JEV-infected
mouse brain tissues. The miR-19b-3p antagomir inhibits cytokine
secretion and activation of astrocytes and microglia, and reduces
neurons damage in the JEV-infected mice (Ashraf et al., 2016). In
this study, miR-21a-5p antagomir treatment delayed the onset of
mice and delayed their weight loss, and the lifespan of the mice
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was extended for about 2 days. After the miR-21a-5p antagomir
treatment, the virus multiplication decreased in the PHEV-
infected mouse brain tissues. MiR-21a-5p exhibited a negative
regulation expression profile with Caskin1 in the brain of PHEV-
infected mouse, which further supports a functional interaction
between the miRNA and mRNA in vivo. These findings indicate
that the miR-21a-5p antagomir treatment reduces the symptoms
in the PHEV-infected mice.
In this study, we identified a new mechanism regulating the
proliferation of PHEV mediated by interaction between miR-21
and Caskin1, which may be exploited to reduce the proliferation
of PHEV for therapeutic applications.
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